Skip to main content

Foresight Global Investors, Inc.

Position in NVO — Novo Nordisk A S

CIK 1973323 PURCHASE, NY

Position in NVO

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$11,759,154
-$1,308,190 QoQ
Shares Held
245,289
-31.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
7.14%
of 13F equity value
Holder Rank
#143
of 1,348 holders
Holding Since
Mar 2024
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Foresight Global Investors, Inc. holds $58,381,119 across 3 Drug Manufacturers - General names. NVO ranks #3 (20.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 NVO
Novo Nordisk A S
This page
245,289 $11,759,154

All Filings in NVO

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,759,154 245,289
2026-03-31 $13,067,344 355,574
2025-12-31 $16,803,170 330,251
2025-09-30 $9,172,164 165,294
2025-06-30 $16,714,297 242,166
2024-06-30 $14,516,943 101,702
2024-03-31 $19,112,340 148,850